Business

Apr,2024, Shanghai KeChow Pharma’s Category 1 innovative drug Tunlametinib Capsules (Chinese trade name: KELUPING) was approved with conditions by China NMPA. Tunlametinib Capsules is indicate for patients with NRAS-mutated advanced melanoma who have failed PD-1/PD-L1 treatment[1]https://www.nmpa.gov.cn/zhuanti/cxylqx/cxypxx/20240315082810127.html. Tunlametinib is a selective mitogen-activated protein kinase 1 and kinase 2 (MEK1/2) kinase inhibitor, which plays an antitumor role by inhibiting the activity of MEK1/2 kinase. The marketing of this drug provides new treatment options for patients with advanced NRAS-mutant melanoma who fail anti- PD-1/PD-L1 therapy. It is reported that tunlametinib was well tolerated…

Nov, 2023. AusperBio（Ausper Biopharma Co.，Ltd. and AusperBio Therapeutics，Inc.）Completed RMB 100 million in Pre-A+ financing by led by InnoPinnacle Fund.

Nov,2023. Shanghai Argo Biopharmaceutical Co., LTD. (hereinafter referred to as Argo Biopharma)  Completed RMB 300 million in Series A+ financing led by SDIC Investment. 

Aponermin for Injection (Brand Name:SHAAITE) of Wuhan HITECK biopharmaceutical Co., Ltd. is approved for marketing by China NMPA, which is used in combination with thalidomide and dexamethasone for the treatment of adult patients with relapsed or refractory Multiple Myeloma after two or more systemic therapies.

October 2023, Essentia Biosciences completed the angel round of financing. From 2022 to 2023, Essentia Biosciences has successively completed angel rounds and angel+ rounds of financing, with a total amount of tens of millions of RMB in all.

Apr, 2023. AstraZeneca’s Gefurulimab injection(ALXN1720) obtains the Implied License from CDE for generalized myasthenia gravis clinical trial.

Top 10 Drugs Losing Patent Exclusivity in US Market in 2021 are Lucentis (Genentech/Roche), Bystolic (AbbVie/Allergan), Vascepa (Amarin), Nothera (Lundbeck), Narcan (Emergent Biosolutions), Brovana (Sunovion), Sutent (Pfizer), Saphris (AbbVie/Allergan), Amitiza (Mallinckrodt), and Feraheme (Amag Pharma).

List of main WHO GMP certified companies in India((Gujarat, Himachal Pradesh, Maharashtra, Telangana etc) for Medicines.

On the eve of the 19th CPhI China Exhibition , the organizer announced Top 20 finished medicine formulation exporters in China 2019. Below is the list.